Mechanisms of biased agonism by Gα i/o -biased stapled peptide agonists of the relaxin-3 receptor
Science Signaling · 2024
DOI: 10.1126/scisignal.abl5880 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2024. Verfasst von Tharindunee Jayakody und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Hauptthemen laut MEDLINE: Relaxin. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: Ministry of Education, Singapore, Academic Research Fund Tier 1, Academic Research Fund Tier 3 funding programme, Japan Science and Technology Agency (JST).
Abstract (Originalsprache)
The neuropeptide relaxin-3 is composed of an A chain and a B chain held together by disulfide bonds, and it modulates functions such as anxiety and food intake by binding to and activating its cognate receptor RXFP3, mainly through the B chain. Biased ligands of RXFP3 would help to determine the molecular mechanisms underlying the activation of G proteins and β-arrestins downstream of RXFP3 that lead to such diverse functions. We showed that the i, i+4 stapled relaxin-3 B chains, 14s18 and d(1-7)14s18, were Gα i/o -biased agonists of RXFP3. These peptides did not induce recruitment of β-arrestin1/2 to RXFP3 by GPCR kinases (GRKs), in contrast to relaxin-3, which enabled the GRK2/3-mediated recruitment of β-arrestin1/2 to RXFP3. Relaxin-3 and the previously reported peptide 4 (an i, i+4 stapled relaxin-3 B chain) did not exhibit biased signaling. The staple linker of peptide 4 and parts of both the A chain and B chain of relaxin-3 interacted with extracellular loop 3 (ECL3) of RXFP3, moving it away from the binding pocket, suggesting that unbiased ligands promote a more open conformation of RXFP3. These findings highlight roles for the A chain and the N-terminal residues of the B chain of relaxin-3 in inducing conformational changes in RXFP3, which will help in designing selective biased ligands with improved therapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- Neurobiology Programme, Life Sciences Institute, National University of Singapore, Singapore.
- Department of Chemistry, University of Colombo, P.O. Box 1490, Colombo 00300, Sri Lanka.
- Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.
- Bioinformatics Institute, A*STAR, 30 Biopolis Street, #07-01 Matrix, Singapore 138671.
- Department of Biological Sciences, National University of Singapore, 6 Science Drive 4, Singapore 117558.
ORCID-Profile: Tharindunee Jayakody, Asuka Inoue, Srinivasaraghavan Kannan, Kouki Kawakami, Krishan Mendis, Deron R Herr, Chandra S Verma, Gavin S Dawe
Förderung
- Ministry of Education, Singapore, Academic Research Fund Tier 1
- Academic Research Fund Tier 3 funding programme
- Japan Science and Technology Agency (JST)
- Japan Agency for Medical Research and Development (AMED)
- Japan Society for the Promotion of Science (JSPS)
- A*STAR
Zitieren
APA
Jayakody, T., Inoue, A., Kannan, S., Nakamura, G., Kawakami, K., Mendis, K., Nguyen, T. B., Li, J., Herr, D. R., Verma, C. S., & Dawe, G. S. (2024). Mechanisms of biased agonism by Gα i/o -biased stapled peptide agonists of the relaxin-3 receptor. Science Signaling. https://doi.org/10.1126/scisignal.abl5880
Vancouver
Jayakody T, Inoue A, Kannan S, Nakamura G, Kawakami K, Mendis K, et al. Mechanisms of biased agonism by Gα i/o -biased stapled peptide agonists of the relaxin-3 receptor. Science Signaling. 2024. doi:10.1126/scisignal.abl5880
BibTeX
@article{Jayakody2024,
author = {Jayakody, Tharindunee and Inoue, Asuka and Kannan, Srinivasaraghavan and Nakamura, Gaku and Kawakami, Kouki and Mendis, Krishan and Nguyen, Thanh-Binh and Li, Jianguo and Herr, Deron R and Verma, Chandra S and Dawe, Gavin S},
title = {Mechanisms of biased agonism by Gα i/o -biased stapled peptide agonists of the relaxin-3 receptor},
journal = {Science Signaling},
year = {2024},
doi = {10.1126/scisignal.abl5880}
}
EUVIMED